Therapeutic Strategies in Dementia - Ritchie, C.W. / Ames, D. / Masters, C.L. / Cummings, J. - Oxford University Press - Neurolo
Consegna gratis sugli ordini superiori a 29 €

Dementia

Dementia
titolo Dementia
autori , , ,
argomenti
editore Clinical Publishing,an imprint of Atlas Medical Publishing Ltd
formato Libro
pagine 376
pubblicazione 2006
ISBN 9781904392583
18app Carta del docente Acquistabile con bonus 18app o Carta del docente
 
88,00 83,60 (-5%)
 
Disponibilità immediata
Spese di spedizione gratis
Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work, leading experts review the therapeutic agents currently available and assess their effectiveness. Also included is an update on recent and on-going clinical trials, the prospects for new therapeutic targets and the development of new biomarkers that will aid recognition of disease and thus earlier intervention.
 

Indice testuale

Preface; Foreword; SECTION I: Current pharmacological approaches in dementia; 1. Cholinesterase inhibitors: synthesis of meta-analysis / randomised controlled trials, CW Ritchie; 2. Cholinesterase inhibitors: long-term studies, R Bullock; 3. Cholinesterase inhibitors: head-to-head studies, R Jones; 4. Ginkgo biloba, RW McCarney, J Warner; 5. Memantine, DW Wilkinson; 6. Anti-oxidants (vitamin E, n-acetyl-cysteine), M Sano; 7. Pharmacoeconomic studies, C Green; SECTION II: Biological developments and future therapies; 8. Disease modifying therapeutic strategies for Alzheimer's disease: targeting the APP/A-beta pathway, CL Masters; 9. Anti-inflammatory drugs, M Woodward; 10. Nicotine and A-beta, A Nordberg; 11. Butyl-cholinesterase, MR Farlow; 12. Sex hormones in the treatment of Alzheimer's disease, D Ames, K Draper; 13. Allosteric potentiating ligands, A Maelicke; 14. The utility of biomarkers in the diagnosis and monitoring of Alzheimer's disease, CW Ritchie; SECTION III: Management of non-cognitive issues in dementia; 15. Non-pharmacological intervention for BPSD, J Cohen-Mansfield; 16. Pharmacological intervention for BPSD, A Shah; 17. Management of affective disorders in dementia, A Thomas; 18. Management of vascular and other risks, R Stewart; 19. Social management of dementia for patient and carer, H Brodaty; SECTION IV: Treatment of non-Alzheimer's disease cognitive impairment; 20. Vascular dementia, T Erkinjuntti; 21. Frontotemporal dementia, M Ikeda; 22. Diffuse Lewy body disease and Parkinson's disease with dementia, R Barber; 23. Mild cognitive impairment (MCI), YE Geda; 24. Delirium, E Sampson; List of abbreviations; Index.

Inserire il codice per il download.

Inserire il codice per attivare il servizio.

Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy.
Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la cookie policy.
Chiudendo questo avviso, navigando in questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all'uso dei cookie.

Acconsento